Doctoral School of Pharmacy

1.

Bíró, K., Révész, R., Pető, Á., Kósa, D., Buchholcz, G., Gyöngyösi, A., Lekli, I., Nemes, D., Bácskay, I., Haimhoffer, Á., Ujhelyi, Z.: Application of new types of surfactants for the development of an adjuvant containing squalene by ultrasonic production.
Tenside Surfactants Deterg. 1, 1-10, 2026.

doi DEA WoS Scopus

Journal metrics:

Q3 Chemical Engineering (miscellaneous) (2025)

Q3 Chemistry (miscellaneous) (2025)

Q3 Condensed Matter Physics (2025)

2.

Harmath, A., Vass, L. T., Jakab, Á., Tóth, Z., Bozó, A., Majoros, L., Pfliegler, V. P., Kovács, R. L.: Clinical and Microbiological Characteristics of Sterile-Site Saccharomyces cerevisiae Infections in a Tertiary-Care Centre.
Mycopathologia. 191 (3), 1-12, (article identifier: 55), 2026.

doi DEA WoS

Journal metrics:

Q1 Agronomy and Crop Science (2025)

Q2 Applied Microbiology and Biotechnology (2025)

Q3 Microbiology (2025)

Q1 Plant Science (2025)

Q1 Veterinary (miscellaneous) (2025)

3.

Révész, R., Mengenli, A. D., Dossi, E., Alsheikh, R., Nemes, D., Ujhelyi, Z., Pető, Á., Rusznyák, Á., Sipos, É., Gyöngyösi, A., Lekli, I., Bácskay, I., Fenyvesi, F., Haimhoffer, Á.: Cyclodextrin Polymer Complexation Improves the Tolerability of Parenteral Oestradiol.
Pharmaceutics. 18 (2), 1-18, (article identifier: 247), 2026.

doi DEA WoS Scopus

Journal metrics:

D1 Pharmaceutical Science (2025)

4.

Imre, A., Kovács, R. L., Jakab, Á., Harmath, A., Németh, B., Nagy, F., Forgács, L., Balázsi, D., Majoros, L., Benkő, Z., Crook, N., Pócsi, I., Pfliegler, V. P.: ENA1 deficiency attenuates Saccharomyces 'boulardii' probiotic yeast virulence in immunosuppressed mouse fungaemia model.
Commun Biol. 9 (1), 1-36, (article identifier: 542), 2026.

doi DEA WoS Scopus

Journal metrics:

D1 Agricultural and Biological Sciences (miscellaneous) (2025)

D1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2025)

D1 Medicine (miscellaneous) (2025)

5.

Fésüs, A., Szilágyi, Z., Beniczky, Z., Varga, E., Matuz, M., Gaál, K., Somodi, S., Bácskay, I., Lekli, I., Vaskó, A.: Evaluation of Antibiotic Use in Patients Admitted to a Hungarian Intensive Care Unit with Pneumonia and Sepsis: retrospective Observational Before-After Study.
Antibiotics. 15 (3), 1-21, (article identifier: 252), 2026.

doi DEA

Journal metrics:

Q1 Biochemistry (2025)

Q1 Infectious Diseases (2025)

Q1 Microbiology (2025)

Q1 Microbiology (medical) (2025)

Q1 Pharmacology (medical) (2025)

D1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (2025)

6.

Vass, A., Király, J., Szabó, E., Kónya, G., Shammas, A., Szegedi, K., Dezső, B., Juhász, É., Halmos, G., Szabó, Z.: Expression of ABCB1, ABCB5, and ABCG2 Transporters in Human Renal Cell Carcinoma and Their Underlying Signaling Pathways.
Curr. Issues Mol. Biol. 48 (7), 1-24, (article identifier: 739), 2026.

doi DEA WoS

Journal metrics:

Q2 Medicine (miscellaneous) (2025)

Q2 Microbiology (2025)

Q2 Microbiology (medical) (2025)

Q2 Molecular Biology (2025)

7.

Kónya, G., Shammas, A., Szabó, E., Tupicza, R., Piran, S. B., Szegedi, K., Vass, A., Juhász, É., Király, J., Dezső, B., Choudhury, M., Szabó, Z., Halmos, G.: Expression of PD-L1 and PD-L2 and Their Association with IFN-[gamma]/STAT1/STAT3 Signaling in Human Clear Cell Renal Cell Carcinoma (ccRCC).
J. Clin. Med. 15 (11), 1-22, (article identifier: 4384), 2026.

doi DEA WoS Scopus

Journal metrics:

Q2 Medicine (miscellaneous) (2025)

8.

Bege, M., Lovas, M., Borbás, A.: From Concept to Clinic: vepdegestrant (ARV 471) Becomes the First Approved PROTAC Drug.
Pharmaceutics. 18 (7), 1-19, (article identifier: 827), 2026.

doi DEA

Journal metrics:

D1 Pharmaceutical Science (2025)

9.

Kopasz, Z., Bereczki, I., Leiner, K., Papp, H., Lőrincz, E. B., Sipos-Szabó, L., Bodó, K., Szabó, E., Madai, M., Zana, B., Erdei, R., Batta, G., Kovács-Öller, T., Varga, Z., Bajusz, D., Kemenesi, G., Borbás, A., Kuczmog, A.: Fusion Inhibition of Zika Virus Entry by a Teicoplanin Pseudoaglycone Derivative with Broad Antiviral Activity.
Pharmaceutics. 18 (7), 1-28, (article identifier: 879), 2026.

doi DEA WoS Scopus

Journal metrics:

D1 Pharmaceutical Science (2025)

10.

Miskei, M., Varga, D., Hornyák, L., Sipos, É., Nagy, É., Li, Q., Karányi, Z., Szabó, Z., DeWeerd, R., Green, A., Szüts, D., Csoma, E., Székvölgyi, L.: Herpes simplex virus type 1 R-loops are targets for APOBEC-mediated mutagenesis.
Genome Biol. 4, 1-14, 2026.

doi DEA

Journal metrics:

D1 Genetics (2025)

D1 Cell Biology (2025)

D1 Ecology, Evolution, Behavior and Systematics (2025)

11.

Rayya, H., Alsheikh, R., Nemes, D., Nagy, L., Regdon, G. J., Bácskay, I., Kristó, K., Pamlényi, K.: Investigation of Cytotoxicity, Permeability, and Stability of Captopril-Loaded Chitosan-Ascorbate Buccal Films.
Pharmaceuticals. 19 (7), 1-19, (article identifier: 1058), 2026.

doi DEA WoS Scopus

Journal metrics:

Q1 Drug Discovery (2025)

Q2 Molecular Medicine (2025)

Q1 Pharmaceutical Science (2025)

12.

Balázsi, D., Meis, J. F., Locke, J. B., Udvarhelyi, G., Tóth, Z., Forgács, L., Kósa, C., Kovács, R. L., Majoros, L.: In Vitro Activity and In Vivo Efficacy in a Murine Model of Rezafungin, Anidulafungin, Caspofungin, and Micafungin Against the Fifth Clade of Candida (Candidozyma) auris.
J. Fungi. 12 (8), 552-569, 2026.

doi DEA

Journal metrics:

Q1 Ecology, Evolution, Behavior and Systematics (2025)

Q2 Microbiology (medical) (2025)

Q1 Plant Science (2025)

13.

Révész, R., Mengenli, A. D., Rusznyák, Á., Kajtár, R., Lekli, I., Bácskay, I., Haimhoffer, Á.: In Vitro and Ex Vivo Studies on the Absorption and Distribution of β-Cyclodextrin Polymer.
Pharmaceutics. 18 (7), 1-18, (article identifier: 854), 2026.

doi DEA WoS Scopus

Journal metrics:

D1 Pharmaceutical Science (2025)

14.

Fodor, P., Zsebik, B., Fenyvesi, F., Szabó, Z., Vass, A., Halmos, G.: In Vitro Evaluation of Combination Therapy with Doxorubicin and Quercetin for Uveal Melanoma.
Curr. Issues Mol. Biol. 48 (6), 1-29, (article identifier: 636), 2026.

doi DEA

Journal metrics:

Q2 Medicine (miscellaneous) (2025)

Q2 Microbiology (2025)

Q2 Microbiology (medical) (2025)

Q2 Molecular Biology (2025)

15.

Balogh, B. N., Klusóczki, Á., Pető, Á., Fehér, P., Ujhelyi, Z., Váradi, J., Bácskay, I.: In Vitro Investigation of Tapinarof-Loaded Nanogels in an Imiquimod-induced HaCaT-THP-1 Co-Culture Model.
Eur. J. Pharm. Sci. 221, 1-15, (article identifier: 107510), 2026.

doi DEA

Journal metrics:

Q1 Pharmaceutical Science (2025)

16.

Homolya, Á., Ahmad, N., Kattoub, R. G., Hőgye, F., Mező, E., Borbás, A.: Photoinitiated thiol-ene reactions of glycals: effect of C2-substitution on reactivity and regio- and stereoselectivity.
Carbohydr. Res. 565, 1-12, (article identifier: 109926), 2026.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry (2025)

Q3 Biochemistry (2025)

Q3 Medicine (miscellaneous) (2025)

Q2 Organic Chemistry (2025)

17.

Harmath, A., Németh, B., Pócsi, I., Majoros, L., Pfliegler, V. P., Kovács, R. L.: Phylogenomic diversity of clinical Saccharomyces cerevisiae and the prevalence of probiotic-derived isolates in a tertiary care center in Hungary.
Microbiol. Spectr. 14 (1), 1-16, (article identifier: 0275025), 2026.

doi DEA WoS

Journal metrics:

Q2 Cell Biology (2025)

Q1 Ecology (2025)

Q2 Genetics (2025)

Q1 Immunology and Microbiology (miscellaneous) (2025)

Q1 Infectious Diseases (2025)

Q1 Microbiology (medical) (2025)

Q1 Physiology (2025)

18.

Arany, P., Papp, Á., Nemes, D., Fehér, P., Ujhelyi, Z., Bácskay, I.: Quality by Design Approach for Hot-Melt Extrusion Coupled Fused Deposition Modeling (HME-FDM) 3D Printing: a Systematic Review.
Pharmaceutics. 18 (5), 1-36, (article identifier: 569), 2026.

doi DEA

Journal metrics:

D1 Pharmaceutical Science (2025)

19.

Ahmad, N., Homolya, Á., Barta, R. A., Herczeg, M., Bényei, A., Iurgenson, N., Bereczki, I., Fedics, G. M., Mándi, A., Kurtán, T., Borbás, A.: Stereoselective synthesis, VCD study and conformational analysis of C-glycosyl isochromans.
Sci Rep. 16 (1), 1-15, (article identifier: 19090), 2026.

doi DEA WoS Scopus

Journal metrics:

Q1 Multidisciplinary (2025)

20.

Kovács, F., Harmath, A., Balázsi, D., Forgács, L., Dienes, Á. Z., Balla, N., Tóth, Z., Bozó, A., Borman, A. M., Majoros, L., Kovács, R. L., Jakab, Á.: Synergistic activity of caspofungin and posaconazole against Candida (Candidozyma) auris biofilms based on phenotypic, transcriptomic, and in vivo insights.
Microbiol. Spectr. 14 (4), 1-18, (article identifier: 0268625), 2026.

doi DEA WoS Scopus

Journal metrics:

Q2 Cell Biology (2025)

Q1 Ecology (2025)

Q2 Genetics (2025)

Q1 Immunology and Microbiology (miscellaneous) (2025)

Q1 Infectious Diseases (2025)

Q1 Microbiology (medical) (2025)

Q1 Physiology (2025)

21.

Alsheikh, R., Nemes, D., Fehér, P., Ujhelyi, Z., Haimhoffer, Á., Papp, Á., Bácskay, I.: Thermosensitive in situ gels for ocular drug delivery: advances in polymer-based formulations.
Eur. J. Pharm. Sci. 218, 1-14, (article identifier: 107439), 2026.

doi DEA

Journal metrics:

Q1 Pharmaceutical Science (2025)

22.

Hosszú, Z., Pártos, P., Mahdavi, M., Ujhelyi, Z., Fehér, P., Haimhoffer, Á., Bácskay, I., Kósa, D., Pető, Á.: The Role and Potential of Nanotechnology in Improving Solubility and Enhancing Bioavailability.
Pharmaceutics. 18 (4), 1-23, (article identifier: 478), 2026.

doi DEA WoS Scopus

Journal metrics:

D1 Pharmaceutical Science (2025)

23.

Szabóné, V. D., Ráduly, Z., Boros-Oláh, B., Nagy, É., Karányi, Z., Halász, L., Bálint, B. L., Vámosi, G., Tóth, E., Bai, P., Santangelo, S., Bossolasco, P., Ratti, A., Géli, V., Pommier, Y., Székvölgyi, L.: TOP1MT rs2293925 is an enhancer-active regulatory SNP that shapes mitochondrial R-loop dynamics.
FEBS J. 7, 1-25, 2026.

doi DEA WoS Scopus

Journal metrics:

D1 Biochemistry (2025)

Q1 Cell Biology (2025)

Q1 Molecular Biology (2025)

24.

Kovács, F., Jakab, Á., Balla, N., Tóth, Z., Balázsi, D., Forgács, L., Harmath, A., Bozó, A., Dienes, Á. Z., Majoros, L., Kovács, R. L.: A comprehensive analysis of the effect of quorum-sensing molecule 3-oxo-C12-homoserine lactone on Candida auris and Candida albicans.
Biofilm. 9, 1-12, (article identifier: 100259), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Applied Microbiology and Biotechnology

Q2 Cell Biology

Q1 Microbiology

Q2 Molecular Biology

25.

Bege, M., Kattoub, R. G., Borbás, A.: Avacincaptad pegol, the second approved aptamer medicine: a mini review.
DRem. 1 (2), 29-45, 2025.

doi DEA

Doctoral School of Pharmacy

Publication list